Microbiome manipulation modifies sex-specific risk for autoimmunity

Janet Markle, Daniel N. Frank, Khosrow Adeli, Martin Von Bergen, Jayne S. Danska

Research output: Contribution to journalArticle

Abstract

Despite growing evidence for a causal role of environmental factors in autoimmune diseases including the rise in disease frequencies over the past several decades we lack an understanding of how particular environmental exposures modify disease risk. In addition, many autoimmune diseases display sexbiased incidence, with females being disproportionately affected but the mechanisms underlying this sex bias remain elusive. Emerging evidence suggests that both host metabolism and immune function is crucially regulated by the intestinal microbiome. Recently, we showed that in the non-obese diabetic (NOD) mouse model of Type 1 Diabetes (T1D), the gut commensal microbial community strongly impacts the pronounced sex bias in T1D risk by controlling serum testosterone and metabolic phenotypes1. Here we present new data in the NOD model that explores the correlations between microbial phylogeny, testosterone levels, and metabolic phenotypes, and discuss the future of microbiome-centered analysis and microbe-based therapeutic approaches in autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)485-493
Number of pages9
JournalGut Microbes
Volume5
Issue number4
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Microbiota
Autoimmunity
Autoimmune Diseases
Sexism
Type 1 Diabetes Mellitus
Testosterone
Inbred NOD Mouse
Environmental Exposure
Phylogeny
Phenotype
Incidence
Serum
Therapeutics

Keywords

  • Immune response to microbiome
  • Metabolome
  • Mouse models of autoimmunity
  • Sex bias in disease
  • Steroid hormones
  • Type 1 diabetes

ASJC Scopus subject areas

  • Microbiology
  • Gastroenterology
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Markle, J., Frank, D. N., Adeli, K., Von Bergen, M., & Danska, J. S. (2014). Microbiome manipulation modifies sex-specific risk for autoimmunity. Gut Microbes, 5(4), 485-493. https://doi.org/10.4161/gmic.29795

Microbiome manipulation modifies sex-specific risk for autoimmunity. / Markle, Janet; Frank, Daniel N.; Adeli, Khosrow; Von Bergen, Martin; Danska, Jayne S.

In: Gut Microbes, Vol. 5, No. 4, 01.01.2014, p. 485-493.

Research output: Contribution to journalArticle

Markle, J, Frank, DN, Adeli, K, Von Bergen, M & Danska, JS 2014, 'Microbiome manipulation modifies sex-specific risk for autoimmunity', Gut Microbes, vol. 5, no. 4, pp. 485-493. https://doi.org/10.4161/gmic.29795
Markle, Janet ; Frank, Daniel N. ; Adeli, Khosrow ; Von Bergen, Martin ; Danska, Jayne S. / Microbiome manipulation modifies sex-specific risk for autoimmunity. In: Gut Microbes. 2014 ; Vol. 5, No. 4. pp. 485-493.
@article{a2f33009822647f48e64746a23240411,
title = "Microbiome manipulation modifies sex-specific risk for autoimmunity",
abstract = "Despite growing evidence for a causal role of environmental factors in autoimmune diseases including the rise in disease frequencies over the past several decades we lack an understanding of how particular environmental exposures modify disease risk. In addition, many autoimmune diseases display sexbiased incidence, with females being disproportionately affected but the mechanisms underlying this sex bias remain elusive. Emerging evidence suggests that both host metabolism and immune function is crucially regulated by the intestinal microbiome. Recently, we showed that in the non-obese diabetic (NOD) mouse model of Type 1 Diabetes (T1D), the gut commensal microbial community strongly impacts the pronounced sex bias in T1D risk by controlling serum testosterone and metabolic phenotypes1. Here we present new data in the NOD model that explores the correlations between microbial phylogeny, testosterone levels, and metabolic phenotypes, and discuss the future of microbiome-centered analysis and microbe-based therapeutic approaches in autoimmune diseases.",
keywords = "Immune response to microbiome, Metabolome, Mouse models of autoimmunity, Sex bias in disease, Steroid hormones, Type 1 diabetes",
author = "Janet Markle and Frank, {Daniel N.} and Khosrow Adeli and {Von Bergen}, Martin and Danska, {Jayne S.}",
year = "2014",
month = "1",
day = "1",
doi = "10.4161/gmic.29795",
language = "English (US)",
volume = "5",
pages = "485--493",
journal = "Gut Microbes",
issn = "1949-0976",
publisher = "Landes Bioscience",
number = "4",

}

TY - JOUR

T1 - Microbiome manipulation modifies sex-specific risk for autoimmunity

AU - Markle, Janet

AU - Frank, Daniel N.

AU - Adeli, Khosrow

AU - Von Bergen, Martin

AU - Danska, Jayne S.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Despite growing evidence for a causal role of environmental factors in autoimmune diseases including the rise in disease frequencies over the past several decades we lack an understanding of how particular environmental exposures modify disease risk. In addition, many autoimmune diseases display sexbiased incidence, with females being disproportionately affected but the mechanisms underlying this sex bias remain elusive. Emerging evidence suggests that both host metabolism and immune function is crucially regulated by the intestinal microbiome. Recently, we showed that in the non-obese diabetic (NOD) mouse model of Type 1 Diabetes (T1D), the gut commensal microbial community strongly impacts the pronounced sex bias in T1D risk by controlling serum testosterone and metabolic phenotypes1. Here we present new data in the NOD model that explores the correlations between microbial phylogeny, testosterone levels, and metabolic phenotypes, and discuss the future of microbiome-centered analysis and microbe-based therapeutic approaches in autoimmune diseases.

AB - Despite growing evidence for a causal role of environmental factors in autoimmune diseases including the rise in disease frequencies over the past several decades we lack an understanding of how particular environmental exposures modify disease risk. In addition, many autoimmune diseases display sexbiased incidence, with females being disproportionately affected but the mechanisms underlying this sex bias remain elusive. Emerging evidence suggests that both host metabolism and immune function is crucially regulated by the intestinal microbiome. Recently, we showed that in the non-obese diabetic (NOD) mouse model of Type 1 Diabetes (T1D), the gut commensal microbial community strongly impacts the pronounced sex bias in T1D risk by controlling serum testosterone and metabolic phenotypes1. Here we present new data in the NOD model that explores the correlations between microbial phylogeny, testosterone levels, and metabolic phenotypes, and discuss the future of microbiome-centered analysis and microbe-based therapeutic approaches in autoimmune diseases.

KW - Immune response to microbiome

KW - Metabolome

KW - Mouse models of autoimmunity

KW - Sex bias in disease

KW - Steroid hormones

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=84920952610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920952610&partnerID=8YFLogxK

U2 - 10.4161/gmic.29795

DO - 10.4161/gmic.29795

M3 - Article

VL - 5

SP - 485

EP - 493

JO - Gut Microbes

JF - Gut Microbes

SN - 1949-0976

IS - 4

ER -